Results 101 to 110 of about 5,643,282 (147)
Some of the next articles are maybe not open access.
Therapeutic advances in heart failure
Cardiovascular Drugs and Therapy, 1988Annual mortality from congestive heart failure ranges from 15% to 60%, depending on the severity of the left ventricular damage and underlying disease. Most controlled trials have been too small to detect any beneficial effect on survival from the newer vasodilator and inotropic drugs.
T, Meinertz, H, Drexler, H, Just
openaire +3 more sources
Recent advances in heart failure
Current Opinion in Cardiology, 2018Acute heart failure continues to be a challenge as there is limited benefit of numerous agents that have been tested. Cardiac resynchronization therapy remains standard of care, yet timing and need for implantable cardiac defibrillator has been brought into question with the recent randomized trials.
Mahwash, Kassi +2 more
openaire +2 more sources
Management of advanced heart failure
Clinical Cornerstone, 2000Congestive heart failure (CHF) due to progressive systolic dysfunction has become a modern-day epidemic. Despite the increased incidence and prevalence, significant progress has been made in the past 10 to 15 years in the treatment of CHF at all stages. The current outlook for patients with newly diagnosed, mild heart failure is encouraging.
Adrian B, Van Bakel, Geoffrey, Chidsey
openaire +3 more sources
Advances in Heart Failure Surgery
Future Cardiology, 2005Heart failure is a major public health problem in the USA and in most Western countries. Nearly 5 million patients in the USA have heart failure with approximately 500,000 patients being diagnosed for the first time each year. Medical therapy is the first-line treatment, and surgery is considered when medical therapy fails or a clear mechanical cause ...
Nicholas C, Dang +2 more
openaire +2 more sources
Heart Failure Clinics, 2016
Heart failure remains one of the most important public health problems in the developed world, with increasing prevalence, high costs, and poor outcomes. Although survival after the diagnosis of heart failure has improved, approximately 50% of patients still die within 5 years after initial diagnosis.
Sunit-Preet Chaudhry, Garrick C. Stewart
openaire +2 more sources
Heart failure remains one of the most important public health problems in the developed world, with increasing prevalence, high costs, and poor outcomes. Although survival after the diagnosis of heart failure has improved, approximately 50% of patients still die within 5 years after initial diagnosis.
Sunit-Preet Chaudhry, Garrick C. Stewart
openaire +2 more sources
Treatment of Advanced Heart Failure
Cardiology in Review, 2000The incidence of chronic heart failure has increased, with a corresponding increase in morbidity and mortality, and has made a substantial financial impact on our society. Improved therapy for heart failure has resulted in a significant prolongation of survival, a decreased number of hospitalizations, and an enhanced quality of life for many patients ...
M, Jessup, S, Brozena
openaire +2 more sources
Advances in heart failure management
Medicina Clínica (English Edition)Heart failure is a pathological condition characterized by substantial prevalence and mortality, particularly in the Western world. Over recent decades, both pharmacological and non-pharmacological interventions have emerged, significantly enhancing patient survival and overall quality of life.
José Luis, Zamorano +1 more
openaire +2 more sources
Management of advanced heart failure: a review
Expert Review of Cardiovascular Therapy, 2018Heart failure (HF) has become a global pandemic. Despite recent developments in both medical and device treatments, HF incidences continues to increase. The current definition of HF restricts itself to stages at which clinical symptoms are apparent.
Kalmonovich, Eran +11 more
openaire +3 more sources
Frailty in Advanced Heart Failure
Heart Failure Clinics, 2016Frailty is defined as a biological syndrome reflecting impaired physiologic reserve and heightened vulnerability to stressors. The evolving profile of heart failure (HF), increased survival of aging patients with complex comorbidities in parallel with the growing population undergoing mechanical circulatory support as lifetime therapy, means that ...
openaire +2 more sources
Advanced Therapies for Advanced Heart Failure in Women
Heart Failure Clinics, 2019Women with advanced heart failure (HF) are underrepresented in trials of short-term and durable mechanical circulatory support although they derive similar benefit. In acute HF, intensive medical and interventional therapies are effective but underutilized.
Marlena V, Habal +2 more
openaire +2 more sources